A novel process for updating recommendations for managing hypertension: Rationale and methods

Canadian Journal of Cardiology

Volumn 16, Issue 9, 2000, Pages 1094-1102

  Zarnke, K B ^a   Campbell, N R C ^a   McAlister, F A ^a   Levine, M ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Health care delivery; Hypertension; Prevention

Indexed keywords

ARTICLE; CANADA; CLINICAL PRACTICE; CLINICAL TRIAL; EVIDENCE BASED MEDICINE; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HUMAN; HYPERTENSION; MEDICAL EXPERT; MEDICAL SOCIETY; POPULATION RESEARCH; PRACTICE GUIDELINE; RISK ASSESSMENT;

CANADA; DELIVERY OF HEALTH CARE; HUMAN; HYPERTENSION; SOCIETIES, MEDICAL; SUPPORT, NON-U.S. GOV'T;

EID: 0033792492     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Canadian recommendations for the management of hypertension
2. International Society of Hypertension guidelines for the management of hypertension
3. Guidelines for management of hypertension: Report of the third working party of the British Hypertension Society
4. Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy
5. Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy
6. Report of the Canadian Hypertension Society Consensus Conference: 2. Nonpharmacologic management and prevention of hypertensive disorders in pregnancy
7. Adherence to management of high blood pressure: Recommendations of the Canadian Coalition for High Blood Pressure Prevention and Control
8. Lifestyle changes to prevent and control hypertension: Do they work? A summary of the Canadian consensus conference
9. Awareness, treatment and control of hypertension in Canada
10. An attempt to improve blood pressure control in the French population: Information and outcome awareness at the general practitioner level
11. Hypertension control and access to medical care in the inner city
12. Health awareness and treatment compliance of high blood pressure among women in a peri-urban colony of Chandigarh, India
13. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: The Captopril Prevention Project (CAPPP) randomised trial
14. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group
15. Recent intervention trials in hypertension initiated in Sweden - HOT, CAPPP and others. Hypertension Optimal Treatment Study. Captopril Prevention Project
16. Inadequate management of blood pressure in a hypertensive population
17. Unsatisfactory blood pressure control - Patient's neglect or doctor's hesitation?
18. Guidelines and the management of hypertensive patients in Canada: Impact, shortcomings and implications for the future
19. Why don't physicians follow clinical practice guidelines? A framework for improvement
20. An overview of 37 randomised trials of blood pressure lowering agents among 270,000 individuals. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration
21. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators
22. Randomised trial of old and new antihypertensive drugs in elderly patients: Cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study
23. Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)
24. Are guidelines following guidelines? The methodological quality of clinical practice guidelines in the peer-reviewed medical literature
25. Report of the Canadian Hypertension Society Consensus Conference: 1. Introduction
26. The periodic health examination. Canadian Task Force on the Periodic Health Examination
27. A novel method of guideline development for the diagnosis and management of mild to moderate hypertension
28. The effects of clinical practice guidelines on patient outcomes in primary care: A systematic review
29. A randomized controlled trial of CQI teams and academic detailing: Can they alter compliance with guidelines?
30. Translating guidelines into practice. A systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines
31. Users' guides to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? Evidence-Based Medicine Working Group
32. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group
33. Users' guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? Evidence-Based Medicine Working Group
34. Users' guides to the medical literature. II. How to use an article about therapy or prevention. B. What were the results and will they help me in caring for my patients? Evidence-Based Medicine Working Group
35. Users' guides to the medical literature. VI. How to use an overview. Evidence-Based Medicine Working Group
36. Users' guides to the medical literature. V. How to use an article about prognosis. Evidence-Based Medicine Working Group
37. Antihypertensive treatment based on conventional or ambulatory blood pressure measurement. A randomized controlled trial. Ambulatory Blood Pressure Monitoring and Treatment of Hypertension Investigators
38. A randomized study comparing a patient-directed hypertension management strategy with usual office-based care
39. Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2
40. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group
41. Risks of untreated and treated isolated systolic hypertension in the elderly: Meta-analysis of outcome trials